Researchers at the University of Massachusetts Amherst have designed non-toxic Salmonella bacteria to deliver viruses that ...

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove ...

Preclinical studies at the Salk Institute laid the foundation for a question now being tested in patients: Can a vitamin ...

A new Yale study reveals that major organ systems in the body aren't just passive structures operating on directions from ...

A small clinical trial led by Dana-Farber Cancer Institute researchers put a Salk Institute idea to the test in patients: that ...

Scientists have uncovered a surprising navigation system in pigeons: iron-filled immune cells in the liver that may act like ...

A vitamin D-based therapy may help remodel the protective barrier surrounding pancreatic tumors, offering a potential new ...

Organs from genetically modified pigs are being used in trials in China and the United States.

Researchers are investigating whether these medications, known as GLP-1 agonists or GLP-1 drugs, could treat everything from ...

An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease is poised to revolutionize the way the cancer is treated, oncologists say.

The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it. The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.